|
|
|
Insider
Information: |
14159, L.p. |
Relationship: |
Director, 10% Owner |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
1,167,526 |
|
Indirect Shares
|
135,452,076 |
|
|
Direct
Value |
$60,365,351 |
|
|
Indirect Value
|
$19,394,027,143 |
|
|
Total
Shares |
136,619,602 |
|
|
Total
Value |
$19,454,392,494 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2014-03-06 |
1,020 |
2014-03-06 |
2,619,123 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-07-19 |
360,231 |
2013-05-23 |
489,039 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-07-26 |
247,063 |
2016-05-17 |
491,774 |
Premium* |
|
Acadia Pharmaceuticals Inc |
ACAD |
Director, 10% Owner |
2013-01-18 |
346,725 |
2016-08-10 |
22,789,815 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2014-12-09 |
107,504 |
2014-12-10 |
24,995,342 |
Premium* |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2013-06-11 |
104,983 |
2013-06-11 |
414,249 |
Premium* |
|
Beigene Ltd |
BGNE |
Director, 10% Owner |
2016-02-08 |
0 |
2016-11-18 |
83,652,734 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
55 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SGEN |
Seagen Inc |
Director |
|
2014-05-09 |
4/A |
B |
$33.73 |
$4,715,922 |
I/I |
138,073 |
372,860 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2014-05-14 |
4 |
OE |
$7.26 |
$217,800 |
I/I |
30,000 |
382,860 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2014-05-15 |
4 |
B |
$34.10 |
$726,356 |
I/I |
21,200 |
383,372 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2014-05-16 |
4 |
A |
$0.00 |
$0 |
I/I |
10,500 |
386,872 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2014-05-16 |
4 |
B |
$34.03 |
$5,734,196 |
I/I |
168,411 |
390,944 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2014-06-02 |
4 |
B |
$34.05 |
$3,225,210 |
I/I |
94,617 |
393,233 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2014-06-03 |
4 |
B |
$34.38 |
$3,457,722 |
I/I |
100,304 |
395,659 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2014-06-04 |
4 |
B |
$36.04 |
$3,145,161 |
I/I |
87,042 |
397,765 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2014-06-05 |
4 |
B |
$37.63 |
$4,526,317 |
I/I |
120,172 |
400,672 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2014-06-06 |
4 |
B |
$37.40 |
$6,546,471 |
I/I |
174,987 |
404,906 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2014-06-09 |
4 |
B |
$38.56 |
$9,772,651 |
I/I |
251,093 |
410,974 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2014-06-12 |
4 |
B |
$39.84 |
$5,112,199 |
I/I |
128,008 |
414,067 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2014-06-13 |
4 |
B |
$39.80 |
$3,533,527 |
I/I |
88,587 |
416,208 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2014-11-06 |
4 |
B |
$33.71 |
$40,805,169 |
I/I |
1,200,972 |
19,408,917 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2014-11-07 |
4 |
B |
$34.91 |
$7,561,461 |
I/I |
211,704 |
19,620,621 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2014-11-10 |
4 |
B |
$35.88 |
$8,787,529 |
I/I |
241,249 |
19,861,870 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2014-12-08 |
4 |
B |
$32.56 |
$15,320,685 |
I/I |
465,316 |
20,327,186 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2014-12-09 |
4 |
B |
$33.28 |
$4,387,345 |
I/I |
128,430 |
20,455,616 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2014-12-09 |
4 |
D |
$0.00 |
$0 |
I/I |
(399,208) |
0 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2014-12-09 |
4 |
A |
$0.00 |
$0 |
D/D |
61,014 |
107,504 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2014-12-10 |
4 |
B |
$34.27 |
$22,501,700 |
I/I |
654,150 |
21,109,766 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2015-10-01 |
4 |
A |
$21.34 |
$119,845 |
I/I |
5,616 |
308,275 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2016-01-01 |
4 |
A |
$35.20 |
$119,962 |
I/I |
3,408 |
308,843 |
0 |
- |
|
BGNE |
Beigene Ltd |
Director |
|
2016-02-08 |
4 |
A |
$0.00 |
$0 |
I/I |
77,742,164 |
70,865,132 |
0 |
- |
|
BGNE |
Beigene Ltd |
Director |
|
2016-02-08 |
4 |
OE |
$0.68 |
$1,750,000 |
I/I |
2,592,593 |
639,600 |
0 |
- |
|
55 Records found
|
|
Page 2 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|